| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |